Pamela Langley Driver, NP
Nurse Practitioner · Toppenish
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 3
- Since medical school
- 5 years
- Graduated 2021
Offices
3 locations · Yakima Valley Farm Workers Clinic · Vidant Medical Group LLC
Looking this up.
Hospitals listed: Vidant Roanoke Chowan Hospital. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Pamela Langley Driver’s office to ask if they take your plan before you enroll.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Vidant Roanoke Chowan HospitalAhoskie, NCAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of ECU Health, which runs 9 hospitalsPatients rate it 3 of 5 · 53% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0, Oct 2024 – Sep 2025
See every measure and the patient survey for Vidant Roanoke Chowan Hospital
Behind the star rating — Deaths: 0 better, 5 the same, 0 worse of 5 measures. Safety: 1 better, 4 the same, 0 worse of 5 measures. Readmissions: 0 better, 7 the same, 1 worse of 8 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.04 (0 to 2.13) · 113 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.06 (0.61 to 1.51) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 9.8 · 52 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 14.4 · 129 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 16.7 · 139 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 12.4 · 96 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4.5 · 792 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.43) · 1,556 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.26 (0.05 to 0.47) · 1,489 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.61 (1.11 to 6.12) · 190 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.93 (1.22 to 4.64) · 180 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.05 (0 to 19.05) · 26 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.85 (0 to 1.91) · 1,339 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.623 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.3 · 239 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 43 · 130 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 46.4 · 134 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.3 · 213 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.5 (3.5 to 8.5) · 41 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.8 (8.2 to 16.4) · 41 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.4 · 103 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.5 (10.1 to 18.2) · 311 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.5) · 61 cases | No different | Jan 2024 – Dec 2024 |
What patients said (301 patients answered, 16% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 3 |
| Recommend hospital | 2 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 82% |
| Staff "always" explained | 64% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 83% |
| Doctors "always" explained things so they could understand | 77% |
| Doctors "always" listened carefully | 82% |
| Doctors "always" treated them with courtesy and respect | 88% |
| Patients who gave a rating of "9" or "10" (high) | 62% |
| Staff "always" explained new medications | 74% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 77% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 57% |
| "YES", patients would definitely recommend the hospital | 53% |
| Staff "always" explained possible side effects | 54% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
Original Medicare doctor bills
$11,495
Medicare paid this office $11,495 for 104 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 66 | $4,101 | $51 |
| Respiratory infectious agent detection by rna for severe acute respiratory syndrome coronavirus 2 (covid 19), influenza a, influenza b, and respiratory syncytial virus, upper respiratory specimen, each reported as detected or not detected | 25 | $3,495 | $140 |
| New patient visit (30+ min) | 24 | $1,153 | $48 |
| Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique | 18 | $653 | $34 |
| Injection of drug or substance under skin or into muscle | 33 | $308 | $9 |
See all 7 services
| Short return visit (20+ min) | 66 | $4,101 | $51 |
| Respiratory infectious agent detection by rna for severe acute respiratory syndrome coronavirus 2 (covid 19), influenza a, influenza b, and respiratory syncytial virus, upper respiratory specimen, each reported as detected or not detected | 25 | $3,495 | $140 |
| New patient visit (30+ min) | 24 | $1,153 | $48 |
| Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique | 18 | $653 | $34 |
| Injection of drug or substance under skin or into muscle | 33 | $308 | $9 |
| Automated urinalysis test | 13 | $29 | $2 |
| Injection, ceftriaxone sodium, per 250 mg | 14 | $21 | None |
Who their Medicare patients are
104 Original Medicare patients in 2024. Average age 70 · Under 65 18% · 85 and older 11% · Women 66% · Also on Medicaid 17% · Health risk score 1.18. At or below the middle of the specialty; the typical nurse practitioner clinician is at 1.42.
Conditions among them: High blood pressure 75% · Chronic kidney disease 37% · Diabetes 36% · Coronary heart disease 21% · Atrial fibrillation 20% · Depression 17% · Heart failure 15% · Cancer 15% · COPD 15%.
The office billed $37,232, Medicare allowed $15,077 and paid $11,495; for 1,078 services of 30 kinds; $254 of it was for drugs given in the office and $11,240 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 104 | 1,078 | 70 | 1.18 | $37,232 | $11,495 |
| 2022 | 15 | 20 | 71 | 0.90 | $2,571 | $415 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
Medicaid work
$138,138 in 2024
Medicaid paid $138,138 for 3,198 billed services this clinician did in 2024, up to 125 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Infectious disease (viral respiratory tract infection), pathogen-specific RNA, 4 targets (severe acute respiratory syndrome coronavirus 2 [SARS-CoV-2], influenza A, influenza B, respiratory syncytial virus [RSV]), upper respiratory specimen, each pathogen reported as detected or not detected | 481 | $56,557 |
| Short return visit (20+ min) | 915 | $45,053 |
| New patient visit (30+ min) | 165 | $11,290 |
| Infectious agent detection by nucleic acid (DNA or RNA); Streptococcus, group A, amplified probe technique | 349 | $8,905 |
| Infectious agent detection by nucleic acid (DNA or RNA); Chlamydia trachomatis, amplified probe technique | 115 | $4,872 |
| Infectious agent detection by nucleic acid (DNA or RNA); Neisseria gonorrhoeae, amplified probe technique | 115 | $4,871 |
| Infectious disease (bacterial vaginosis and vaginitis), multiplex amplified probe technique, for detection of bacterial vaginosis-associated bacteria (BVAB-2, Atopobium vaginae, and Megasphera type 1), algorithm reported as detected or not detected and separate detection of Candida species (C. albicans, C. tropicalis, C. parapsilosis, C. dubliniensis), Candida glabrata/Candida krusei, and trichomonas vaginalis, vaginal-fluid specimen, each result reported as detected or not detected | 97 | $3,420 |
| Clinic visit/encounter, all-inclusive | 25 | $1,540 |
| URINE PREGNANCY TEST | 149 | $1,014 |
| Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular | 44 | $568 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; automated, without microscopy | 24 | $50 |
| Review of all medications by a prescribing practitioner or clinical pharmacist (such as, prescriptions, OTCs, herbal therapies and supplements) documented in the medical record (COA) | 254 | $0 |
| 2024 | 3,198 | 15 | 125 | $138,138 |
| 2023 | 376 | 2 | 30 | $18,836 |
| 2022 | 291 | 4 | 33 | $14,802 |
See the largest Medicaid services in earlier years
2023
| Clinic visit/encounter, all-inclusive | 284 | $18,323 |
| Short return visit (20+ min) | 92 | $513 |
2022
| Clinic visit/encounter, all-inclusive | 186 | $12,567 |
| Short return visit (20+ min) | 64 | $968 |
| Initial comprehensive preventive medicine evaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, new patient; adolescent (age 12 through 17 years) | 25 | $862 |
| Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit | 16 | $406 |
Drugs they prescribed that Part D paid
$127,412
Pharmacies billed $127,412 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
1,340 generic and fewer than 11 brand-name prescriptions · $127,412 in drug cost · 117 antibiotic prescriptions to 101 people · 17 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Farxiga | 34 | $39,033 | $1,148 |
| Januvia | 20 | $18,393 | $920 |
| Jardiance | 11 | $11,238 | $1,022 |
| Trelegy Ellipta | 12 | $7,919 | $660 |
| Azelastine | 106 | $2,411 | $23 |
See all 40 drugs
| Farxiga | 34 | $39,033 | $1,148 |
| Januvia | 20 | $18,393 | $920 |
| Jardiance | 11 | $11,238 | $1,022 |
| Trelegy Ellipta | 12 | $7,919 | $660 |
| Azelastine | 106 | $2,411 | $23 |
| Fluticasone Propionate | 127 | $1,278 | $10 |
| Atorvastatin | 58 | $779 | $13 |
| Albuterol Sulfate Hfa | 31 | $751 | $24 |
| Ventolin Hfa | 12 | $671 | $56 |
| Methylprednisolone | 93 | $598 | $6 |
| Levothyroxine | 36 | $420 | $12 |
| Levocetirizine Dihydrochloride | 12 | $403 | $34 |
| Valsartan | 11 | $353 | $32 |
| Rosuvastatin | 26 | $347 | $13 |
| Losartan | 32 | $328 | $10 |
| Montelukast | 26 | $315 | $12 |
| Metoprolol | 29 | $270 | $9 |
| Quetiapine Fumarate Er | 13 | $230 | $18 |
| Nitrofurantoin Mono-Macro | 18 | $224 | $12 |
| Sertraline | 16 | $209 | $13 |
| Potassium Chloride | 12 | $206 | $17 |
| Amlodipine Besylate | 47 | $205 | $4 |
| Omeprazole | 26 | $200 | $8 |
| Tamsulosin | 17 | $177 | $10 |
| Azithromycin | 32 | $173 | $5 |
| Lisinopril | 29 | $166 | $6 |
| Amoxicillin-Clavulanate Potass | 17 | $162 | $10 |
| Pioglitazone | 18 | $135 | $8 |
| Metformin | 31 | $129 | $4 |
| Doxycycline Hyclate | 15 | $113 | $8 |
| Metformin Hcl Er | 13 | $111 | $9 |
| Mupirocin | 15 | $106 | $7 |
| Lisinopril-Hydrochlorothiazide | 11 | $98 | $9 |
| Metoprolol | 13 | $90 | $7 |
| Allopurinol | 18 | $89 | $5 |
| Hydrochlorothiazide | 45 | $83 | $2 |
| Gabapentin | 17 | $75 | $4 |
| Prednisone | 18 | $67 | $4 |
| Pravastatin | 14 | $58 | $4 |
| Simvastatin | 12 | $18 | $2 |
Year by year
| 2024 | 1,537 | 247 | None | None | $127,412 |
| 2023 | 1,657 | 102 | 1% (19) | None | $187,458 |
| 2022 | 570 | 76 | 3% (14) | None | $43,900 |
| 2021 | 16 | None | 0% (0) | 0% | $110 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 42 drugs
| Farxiga | 54 | $49,184 | $911 |
| Levemir Flexpen | 17 | $6,434 | $378 |
| Atorvastatin | 79 | $1,516 | $19 |
| Albuterol Sulfate Hfa | 42 | $1,209 | $29 |
| Synthroid | 14 | $1,064 | $76 |
| Potassium Chloride | 22 | $980 | $45 |
| Valsartan-Hydrochlorothiazide | 18 | $896 | $50 |
| Levothyroxine | 33 | $782 | $24 |
| Amlodipine Besylate | 80 | $715 | $9 |
| Rosuvastatin | 37 | $583 | $16 |
| Hydrocodone-Acetaminophen | 17 | $542 | $32 |
| Metoprolol | 29 | $497 | $17 |
| Omeprazole | 40 | $490 | $12 |
| Montelukast | 56 | $482 | $9 |
| Fluticasone Propionate | 42 | $477 | $11 |
| Pravastatin | 21 | $451 | $21 |
| Esomeprazole Magnesium | 13 | $445 | $34 |
| Tamsulosin | 25 | $444 | $18 |
| Azelastine | 11 | $440 | $40 |
| Sertraline | 22 | $426 | $19 |
| Losartan | 33 | $425 | $13 |
| Lisinopril | 52 | $412 | $8 |
| Triamterene-Hydrochlorothiazid | 15 | $390 | $26 |
| Pantoprazole | 18 | $358 | $20 |
| Gabapentin | 23 | $352 | $15 |
| Ipratropium | 11 | $312 | $28 |
| Metoprolol | 29 | $294 | $10 |
| Lisinopril-Hydrochlorothiazide | 16 | $288 | $18 |
| Metformin | 42 | $273 | $7 |
| Duloxetine | 11 | $261 | $24 |
| Levetiracetam | 17 | $233 | $14 |
| Allopurinol | 24 | $226 | $9 |
| Prednisone | 29 | $178 | $6 |
| Hydrochlorothiazide | 44 | $175 | $4 |
| Metformin Hcl Er | 12 | $170 | $14 |
| Amoxicillin-Clavulanate Potass | 18 | $169 | $9 |
| Furosemide | 25 | $157 | $6 |
| Pioglitazone | 13 | $155 | $12 |
| Glipizide | 11 | $134 | $12 |
| Isosorbide Mononitrate Er | 12 | $110 | $9 |
| Simvastatin | 14 | $76 | $5 |
| Meloxicam | 12 | $36 | $3 |
2022: 14 drugs
| Atorvastatin | 24 | $471 | $20 |
| Albuterol Sulfate Hfa | 14 | $462 | $33 |
| Hydrocodone-Acetaminophen | 14 | $422 | $30 |
| Gabapentin | 22 | $382 | $17 |
| Montelukast | 30 | $359 | $12 |
| Fluticasone Propionate | 22 | $312 | $14 |
| Amoxicillin-Clavulanate Potass | 13 | $270 | $21 |
| Amlodipine Besylate | 24 | $268 | $11 |
| Omeprazole | 11 | $141 | $13 |
| Furosemide | 11 | $117 | $11 |
| Losartan | 11 | $105 | $10 |
| Metformin | 14 | $67 | $5 |
| Lisinopril | 17 | $61 | $4 |
| Prednisone | 11 | $44 | $4 |
Money from drug and device companies
$35 in 2024
| 2024 | 2 | 2 | None | $35 |
| 2023 | 5 | 8 | None | $146 |
| 2022 | 4 | 4 | None | $53 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Novo Nordisk | Ozempic | $17 | 1 payment
|
| GlaxoSmithKline | Bexsero | $17 | 1 payment
|
See all 2 published payments
| Novo Nordisk | Meals · 2024-04-22 | Ozempic | $17 |
| GlaxoSmithKline | Meals · 2024-03-20 | Bexsero | $17 |
See earlier years (2023, 2022)
2023: $146
| Exact Sciences | Cologuard Collection Kit | $63 | 3 payments
|
| Novo Nordisk | Ozempic | $31 | 2 payments
|
| Lilly USA | Jardiance | $19 | 1 payment
|
| Pfizer | Prevnar 20 | $19 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Breztri | $14 | 1 payment
|
2022: $53
| Merck Sharp & Dohme | Gardasil 9 | $15 | 1 payment
|
| Almatica Pharma | Gralise | $14 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $12 | 1 payment
|
| Currax Pharmaceuticals | Contrave | $12 | 1 payment
|
Professional record
- NPI
- 1902429053
- Licence
- NC 5014784
- Group
- Yakima Valley Farm Workers Clinic · Vidant Medical Group LLC
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Nurse practitioner (363L00000X); Federal specialty code 363LF0000X (363LF0000X)
- Mailing address
- Po Box 190, Toppenish, WA, 98948
- NPI first listed
- 2020-05-23
- NPI last updated
- 2026-01-19
- NPI record certified
- 2026-01-19
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 120 Medical Drive Unc-Ch Son:Carrington Hall, Chapel Hill, NC, 27599